First Trust Advisors
AXSM icon

First Trust Advisors’s Axsome Therapeutics AXSM Stock Holding History

First Trust Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118M Sell
482,061
-95,418
-17% -$20.7M 0.07% 340
2026
Q1 		$97.6M Buy
577,479
+534,066
+1,230% +$92.2M 0.07% 357
2025
Q4 		$7.93M Buy
43,413
+6,276
+17% +$876K 0.01% 1198
2025
Q3 		$4.51M Sell
37,137
-25,023
-40% -$2.82M ﹤0.01% 1422
2025
Q2 		$6.49M Buy
62,160
+33,209
+115% +$3.52M 0.01% 1239
2025
Q1 		$3.38M Sell
28,951
-25,629
-47% -$2.92M ﹤0.01% 1521
2024
Q4 		$4.62M Buy
54,580
+11,488
+27% +$1.06M ﹤0.01% 1403
2024
Q3 		$3.87M Buy
43,092
+16,501
+62% +$1.44M ﹤0.01% 1459
2024
Q2 		$2.14M Sell
26,591
-38,921
-59% -$2.88M ﹤0.01% 1679
2024
Q1 		$5.23M Sell
65,512
-4,397
-6% -$369K 0.01% 1265
2023
Q4 		$5.56M Buy
+69,909
New +$4.67M 0.01% 1204

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

First Trust Advisors's AXSM Position: Q2 2026 in Review

First Trust Advisors reduced its Axsome Therapeutics (AXSM) stake by 17% in Q2 2026, selling an estimated $20.7M and leaving 482,061 shares worth $118M. The position accounts for 0.07% of the portfolio, ranked #340.

First Trust Advisors first reported a position in AXSM in Q4 2023 and has held it in 11 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • First Trust Advisors held 482,061 shares of Axsome Therapeutics worth $118M as of Q2 2026.
  • First Trust Advisors sold 95,418 Axsome Therapeutics shares in Q2 2026, an estimated $20.7M.
  • Axsome Therapeutics made up 0.07% of First Trust Advisors's portfolio in Q2 2026, its #340 holding.
  • First Trust Advisors first reported a position in Axsome Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.